Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Luo
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease	Active, not recruiting	3	9541	Europe, Canada, Japan, US, RoW	Obicetrapib, Placebo	NewAmsterdam Pharma, Monash University	Atherosclerotic Cardiovascular Disease	11/26	11/26
UCEADP-BCS, NCT06775977: Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer: a Prospective, Observational Study	Recruiting	N/A	480	RoW	Contrast Enhanced Ultrasound (CEUS)	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Bladder Cancer, Staging, Contrast Enhanced Ultrasound	12/25	12/25
NCT06606600: Impacts of Kebbi Robot Intervention for Older Adults with Mild Dementia	Recruiting	N/A	136	RoW	Intensive Kebbi robot interventions	National Tainan Junior College of Nursing	Mild Cognitive Impairment (MCI)	07/25	07/25
NCT06904027: A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders	Not yet recruiting	N/A	40	RoW	Glycerol phenylbutyrate Oral Liquid, HPN-100, GT4P, Glyceryl tri-(4-phenylbutyrate), RAVICTI	Tongji Hospital	Urea Cycle Disorders	10/26	07/31

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Luo
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease	Active, not recruiting	3	9541	Europe, Canada, Japan, US, RoW	Obicetrapib, Placebo	NewAmsterdam Pharma, Monash University	Atherosclerotic Cardiovascular Disease	11/26	11/26
UCEADP-BCS, NCT06775977: Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer: a Prospective, Observational Study	Recruiting	N/A	480	RoW	Contrast Enhanced Ultrasound (CEUS)	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Bladder Cancer, Staging, Contrast Enhanced Ultrasound	12/25	12/25
NCT06606600: Impacts of Kebbi Robot Intervention for Older Adults with Mild Dementia	Recruiting	N/A	136	RoW	Intensive Kebbi robot interventions	National Tainan Junior College of Nursing	Mild Cognitive Impairment (MCI)	07/25	07/25
NCT06904027: A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders	Not yet recruiting	N/A	40	RoW	Glycerol phenylbutyrate Oral Liquid, HPN-100, GT4P, Glyceryl tri-(4-phenylbutyrate), RAVICTI	Tongji Hospital	Urea Cycle Disorders	10/26	07/31